NCT05341310

Brief Summary

The aims of the present study is to investigate the efficacy of a co-designed individually-tailored Internet intervention for parents of children with ADHD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 11, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 22, 2022

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2024

Completed
Last Updated

October 18, 2024

Status Verified

October 1, 2024

Enrollment Period

1.8 years

First QC Date

April 11, 2022

Last Update Submit

October 17, 2024

Conditions

Keywords

Internet interventionindividually-tailored interventionparental distressADHDchildren

Outcome Measures

Primary Outcomes (1)

  • Changes in parental psychological distress

    The Patient Health Questionnaire will be used to assess changes in parental anxiety and depressive symptoms from pre-treatment to post-treatment and follow-up. Scores range between 0 and 12, higher scores indicate higher anxiety and depressive symptoms.

    Baseline, 4 weeks and follow-up at 3 months after treatment termination

Secondary Outcomes (6)

  • Changes in child ADHD symptoms

    Baseline, 4 weeks and follow-up at 3 months after treatment termination

  • Changes in parenting

    Baseline, 4 weeks and follow-up at 3 months after treatment termination

  • Changes in parent-child closeness

    Baseline, 4 weeks and follow-up at 3 months after treatment termination

  • ADHD adult

    Baseline, 4 weeks and follow-up at 3 months after treatment termination

  • Changes in ADHD Knowledge

    Baseline, 4 weeks and follow-up at 3 months after treatment termination

  • +1 more secondary outcomes

Study Arms (2)

ADHDCoach

EXPERIMENTAL

Participants in the experimental group will have access to an individually-tailored Internet intervention developed for the present study. The intervention in clinician-guided and it consists of nine modules delivered for four weeks. The Internet Intervention, called ADHDCoach, is based on an existent Behavioral Parent training protocol, an intervention that was previously tested in a randomized controlled trial with Romanian children. The contents for parent modules were developed according to Rational Emotive and Behavioral Therapy.

Behavioral: ADHDCoachOther: Treatment as usual

Treatment as usual

ACTIVE COMPARATOR

Treatment as usual at the outpatient clinic

Other: Treatment as usual

Interventions

ADHDCoachBEHAVIORAL

ADHDCoach is an individually-tailored intervention to reduce parents' of children diagnosed with ADHD distress.

ADHDCoach

Treatment as usual in the outpatient clinic

ADHDCoachTreatment as usual

Eligibility Criteria

Age6 Years - 11 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Parent of a child diagnosed with ADHD
  • Child aged between 5-11 years
  • Have Internet access
  • Have ability to read and write in Romanian
  • No medication/ or stable dose of pharmacological treatment

You may not qualify if:

  • Other ongoing psychological treatment or counselling for mental health problems (currently undergoing psychotherapy or participating in a parenting program for child ADHD)
  • Recent (within the past 3 months) changes in the dose of medication
  • Serious psychopathology requiring immediate clinical attention (e.g., severe depressive symptoms)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Babes-Bolyai University

Cluj-Napoca, 400015, Romania

Location

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Officials

  • Costina R Păsărelu, Ph.D

    Babes-Bolyai University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

April 11, 2022

First Posted

April 22, 2022

Study Start

March 1, 2022

Primary Completion

December 20, 2023

Study Completion

March 30, 2024

Last Updated

October 18, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations